(Total Views: 553)
Posted On: 08/29/2022 8:25:40 AM
Post# of 10
$TMBR Timber Pharmaceuticals is the play of the week!
Today Aug. 29th, 2022 news:
Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress
New from Aug. 26, 2022:
Timber Pharmaceuticals Announces Publication of Results from Phase 2b CONTROL Study of FDA-Designated Breakthrough Therapy TMB-001 in the Journal of the American Academy of Dermatology
Lots of potential here and coming off a 52 week low. This could hit a $1.00 fast and is part of the NYSE. Good luck to all.
EliteStockPicks
Today Aug. 29th, 2022 news:
Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress
New from Aug. 26, 2022:
Timber Pharmaceuticals Announces Publication of Results from Phase 2b CONTROL Study of FDA-Designated Breakthrough Therapy TMB-001 in the Journal of the American Academy of Dermatology
Lots of potential here and coming off a 52 week low. This could hit a $1.00 fast and is part of the NYSE. Good luck to all.
EliteStockPicks
(0)
(0)
